Westchester Capital Management (New York)’s Verona Pharma VRNA Stock Holding History

Westchester Capital Management (New York)’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-483,655	Closed	-$51.6M	–	312
2025 Q3	$51.6M	Buy	+483,655	New	+$50.5M	2.36%	10

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Westchester Capital Management (New York)'s VRNA Position: Q4 2025 in Review

Westchester Capital Management (New York) sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 483,655 shares — an estimated $51.6M sold.

Westchester Capital Management (New York) first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $51.6M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Westchester Capital Management (New York) reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Westchester Capital Management (New York) sold 483,655 Verona Pharma shares in Q4 2025, an estimated $51.6M.
Westchester Capital Management (New York) first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Westchester Capital Management (New York)'s Verona Pharma position peaked at $51.6M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.